Skip to main content
Menu
US

Revvity Blog

Powering innovation from discovery to cure.

Unraveling the power of unique molecular identifiers in cancer research.
NGS - 2 min read
Drug Development
Drug repurposing for antiviral therapies: research and strategies with high throughput screening.
Drug Development
How to streamline your mAb hybridoma screening.
Drug Development
Revvity Omics: expertise in drug development, from inception to market.
Drug Development
An overview of RAS protein mutations in cancer and KRAS-targeted therapeutics.

Questions?
We’re here to help.

Contact us